Streetbeat News

Price Targets

CC

RBC Capital analyst Arun Viswanathan maintains a 'Sector Perform' rating on Chemours (NYSE:CC) and lowers the price target from $30 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:34 pm

NOVA

RBC Capital analyst Elvira Scotto maintains an 'Outperform' rating on Sunnova Energy Intl (NYSE:NOVA) but lowers the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:33 pm

PFS

RBC Capital analyst Jon Arfstrom has maintained an 'Outperform' rating on Provident Financial Services (PFS), but lowered the price target from $19 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:31 pm

NWL

RBC Capital analyst Nik Modi has maintained a 'Sector Perform' rating on Newell Brands (NASDAQ:NWL) but lowered the price target from $12 to $9.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:30 pm

NOV

RBC Capital analyst Keith Mackey has maintained a 'Sector Perform' rating on NOV (NYSE:NOV) and raised the price target from $23 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:29 pm

LHX

RBC Capital analyst Ken Herbert has maintained an 'Outperform' rating on L3Harris Technologies (NYSE:LHX) but lowered the price target from $240 to $225.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:25 pm

BYDDF

LI

NIO

TSLA

XPEV

BYD Company Limited reported Q3 2023 earnings that beat analyst expectations, with sales of 162 billion RMB ($22.1 billion), a 38.49% improvement YoY, and net profit of 9.7 billion RMB, up 81% YoY. Despite the strong performance, HSBC cut its price target for BYD by 4% due to increased A-share and H-share spread, but maintained its Buy rating. HSBC also predicts Q4 earnings will rise and forecasts an additional increase in earnings growth of 7-16% for the 2023-2025 period.

Portfolio Pulse from Daniel Harrison

October 30, 2023 | 5:52 pm

KNSL

RBC Capital analyst Scott Heleniak has maintained an 'Outperform' rating on Kinsale Cap Gr (NYSE:KNSL), but lowered the price target from $435 to $410.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 5:48 pm

HCAT

RBC Capital analyst Sean Dodge has maintained a 'Sector Perform' rating on Health Catalyst (NASDAQ:HCAT) but lowered the price target from $13 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 5:46 pm

GLPI

RBC Capital analyst Brad Heffern maintains an 'Outperform' rating on Gaming and Leisure Properties (GLPI), but has lowered the price target from $54 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 5:44 pm